Top Stories
-
Stephanie Cosentino, PhD, Associate Professor of Neuropsychology, and colleagues are working on developing screening tools to detect subjective cognitive decline and more advanced forms of memory loss
Topic
-
A new study done by Dr. Jennifer Manly, professor of neuropsychology, and colleagues, found that the quality of the high school you attend may have an impact on cognition later in life
Topic
-
Richard Mayeux, MD, chair of the Department of Neurology at CUMC and colleagues are investigating a set of blood tests that may help correctly diagnose Alzheimer disease in low-resource environments
Topic
-
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
Latest News
- February 19, 2023
As Davangere Devanand, a neurologist at CUIMC, combed through the reams of scientific data on Alzheimer’s, he stumbled across a surprising idea – could an infection be involved in driving the disease?
- February 3, 2023
Of all the possible contributors, intense physical activity was the likely disease-modifying factor, Davangere Devanand, MD, of CUIMC, and co-authors wrote in Alzheimer's & Dementia
- September 28, 2022
Dr. Lawrence Honig, professor of neurology at Columbia University Irving Medical Center, speaks about the new Alzheimer drug trial results
- July 25, 2022
"Hispanics and individuals of African ancestry have been significantly underrepresented in research of Alzheimer’s disease, although engaging underserved minorities is critical..." says Dr. Reitz
Topic
- July 5, 2022
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
- May 24, 2022
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
Topic
- May 22, 2022
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease.
- April 28, 2022
A recent look inside a baby zebrafish's transparent brain offers clues to how we remember and how we forget.
- April 18, 2022
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
- December 28, 2021
Columbia research seven years in the making highlights potential therapeutic target for neurodegenerative disease
